Simposi
Clinical And Experimental Aspects Of Novel Antidiabetic Therapies . From The Gut And The Kidney Towards The Cardiovascular System : The Last Ten Years Of The Antidiabetic Drugs.
26 ottobre 2017 / 14.00-16.00
180 |
The point of view of the diabetologist Angelo Avogaro (Padova) |
181 |
The point of view of the cardiologist Pasquale Perrone Filardi (Naples) |
182 |
A matter of safety? Annalisa Capuano (Naples) |
183 |
The EMPAREG-OUTCOME study and the dilemma of the cardiovascular protection Edoardo Mannucci (Florence) |
184 |
What the research tells us: mechanistic hypotheses of empaglifozin protection Raffaele Coppini (Florence) |